Geneva, July 7 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127034) titled 'Mechanism-Based Assessment of In-Stent Restenosis Using a Hybrid IVUS/OCT System and Its Impact on Optimizing Periprocedural Reintervention Strategies' on June 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University
Condition:
Coronary Artery Disease
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-07-01
Target Sample Size: ISR group:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=327199
Published by HT Digital Content Services with permission f...